| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-07 | NCT07752264 A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy | Phase 1/2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06464991 | A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) | Multiple Myeloma | Recruiting |
| Phase 2 | |||
| NCT07055724 | Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis | AL Amyloidosis | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05091541 | A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's… | B-cell Non-Hodgkin's Lymphoma | Not Yet Recruiting |
| NCT07510100 | Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Multiple Myeloma | Not Yet Recruiting |
| NCT07752264 | A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy | Refractory Immune-mediated Necrotizing Myopathy | Not Yet Recruiting |
| Phase 1 | |||
| NCT05759793 | A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma… | Relapsed/Refractory Multiple Myeloma | Recruiting |
| NCT06743503 | UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies | Large B-cell Lymphoma | Recruiting |
| NCT07109986 | UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus… | Systemic Lupus Erythematosus | Recruiting |
| NCT05181501 | A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk… | Multiple Myeloma | Not Yet Recruiting |
| Not specified | |||
| NCT07028970 | Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection | Multiple Myeloma | Recruiting |